Circulating angiopopietin-1 correlates with the clinical course of multiple organ dysfunction syndrome and mortality in patients with severe sepsis.

Circulating angiopopietin-1 correlates with the clinical course of multiple organ dysfunction syndrome and mortality in patients with severe sepsis.
复制标题

DOI:
10.1097/md.0000000000000878
复制
发表时间:
2015-05
期刊:
影响因子:
1.6
通讯作者:
Kuo HP
Kuo HP
中科院分区:
医学4区
文献类型:
--
作者:
Lin SM;Chung FT;Kuo CH;Chou PC;Wang TY;Chang PJ;Lo YL;Huang CD;Lin HC;Wang CH;Kuo HP

文献摘要

被引文献

相似文献

测定脓毒症诱导的多器官功能障碍综合征(MODS)患者中血管生成素(Ang)-1、Ang -2、Tie -2和血管内皮生长因子(VEGF)的血浆浓度,并确定它们与死亡率的关联。 该研究前瞻性地招募了一家三级医院重症监护病房的96例连续的严重脓毒症患者。在脓毒症第1、3和7天测定患者的血浆Ang -1、Ang -2、Tie -2和VEGF水平以及MODS情况。进行单变量和Cox比例风险分析以建立一个预后模型。 MODS患者在第1、3和7天的血浆Ang -1浓度持续低于非MODS患者(第1天:4.0 ± 0.5对8.0 ± 0.5 ng/mL,P < 0.0001;第3天,3.2 ± 0.6对7.3 ± 0.5 ng/mL,P < 0.0001;第7天,2.8 ± 0.6对10.4 ± 0.7 ng/mL,P < 0.0001)。在脓毒症第7天MODS缓解的患者中,Ang -1水平从第1天开始升高(4.7 ± 0.6 ng/mL对9.1 ± 1.4 ng/mL,n = 43,P = 0.004)。在严重脓毒症第1天(4.0 ± 0.5对7.1 ± 0.5 ng/mL,P < 0.0001)、第3天(3.8 ± 0.6对7.1 ± 0.5 ng/mL,P < 0.0001)和第7天(4.7 ± 0.7对11.0 ± 0.8 ng/mL,P < 0.0001),未存活者的血浆Ang -1水平低于存活者。相反,仅在第1天未存活者的血浆Ang -2水平高于存活者(15.8 ± 2.0对9.5 ± 1.2 ng/mL,P = 0.035)。VEGF和Tie -2水平与MODS和死亡率无关。Ang -1水平低于中位数是死亡率的唯一独立预测因子(风险比,2.57;95%置信区间1.12 - 5.90,P = 0.025)。 Ang -1水平持续降低与脓毒症患者的MODS以及随后的死亡率相关。
To determine plasma concentrations of angiopoietin (Ang)-1, Ang-2, Tie-2, and vascular endothelial growth factor (VEGF) in patients with sepsis-induced multiple organ dysfunction syndrome (MODS) and determine their association with mortality. The study prospectively recruited 96 consecutive patients with severe sepsis in a l intensive care unit of a tertiary hospital. Plasma Ang-1, Ang-2, Tie-2, and VEGF levels and MODS were determined in patients on days 1, 3, and 7 of sepsis. Univariate and Cox proportional hazards analysis were performed to develop a prognostic model. Days 1, 3, and 7 plasma Ang-1 concentrations were persistently decreased in MODS patients than in non-MODS patients (day1: 4.0 ± 0.5 vs 8.0 ± 0.5 ng/mL, P < 0.0001; day 3, 3.2 ± 0.6 vs 7.3 ± 0.5 ng/mL, P < 0.0001, day 7, 2.8 ± 0.6 vs 10.4 ± 0.7 ng/mL, P < 0.0001). In patients with resolved MODS on day 7 of sepsis, Ang-1 levels were increased from day 1 (4.7 ± 0.6 ng/mL vs 9.1 ± 1.4 ng/mL, n = 43, P = 0.004). Plasma Ang-1 levels were lower in nonsurvivors than in survivors on days 1 (4.0 ± 0.5 vs 7.1 ± 0.5 ng/mL, P < 0.0001), 3 (3.8 ± 0.6 vs 7.1 ± 0.5 ng/mL, P < 0.0001), and 7 (4.7 ± 0.7 vs 11.0 ± 0.8 ng/mL, P < 0.0001) of severe sepsis. In contrast, plasma Ang-2 levels were higher in nonsurvivors than in survivors only on day 1 (15.8 ± 2.0 vs 9.5 ± 1.2 ng/mL, P = 0.035). VEGF and Tie-2 levels were not associated with MODS and mortality. Ang-1 level less than the median value was the only independent predictor of mortality (hazard ratio, 2.57; 95% CI 1.12–5.90, P = 0.025). Persistently decreased Ang-1 levels are associated with MODS and subsequently, mortality in patients with sepsis.